BCL2L11 and Parkinson disease: Consistently, in 6-Hydroxydopamine Hydrobromide (6-OHDA)-induced PD mice, miR-221 overexpression targets BIM, inhibits the Bax/caspase-3 apoptotic pathway, rescues dopaminergic neuron loss, and improves motor function [60].